Clinical trial
Stomach and Esophageal Cancers in Northern Iran
NCT00339742 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00339742 |
|---|---|
| Title | Stomach and Esophageal Cancers in Northern Iran |
| Official title | Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Phase I: Case-Control Study |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Esophageal Cancer |
| Enrollment | 1,163 |
| Start date | Mar 25, 2003 |
| Primary completion | Mar 26, 2010 |
| Completion | Feb 13, 2020 |
| First posted | Jun 21, 2006 |
| Last update posted | Dec 11, 2020 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: